There is new cancer drug known as Abiraterone which has so far produced very encouraging results in the treatment of advanced Prostate Cancer. Prostate cancer is a very frequent form of cancer in our society. Each year 680,000 men worldwide are diagnosed with Prostate Cancer and as many as 220,000 will die of this disease. Numerous studies have proven that the hormone Testosterone stimulates the growth of Prostate Cancer and that inhibition of this hormone leads to a decrease in the size and the growth of Prostate Cancer.
Abiraterone, is a new medication which has the promise of treating Prostate Cancer by blocking an enzyme known as the CYP17 enzyme which plays a role in the production of Testosterone in men with Prostate Cancer.
The results of the treatments provided for men with advanced Prostate Cancer with this new medication are as yet preliminary, but they are very encouraging. This medication is now currently undergoing clinical trials and if all goes well, it is expected to be on the market in the year 2011. These concepts and many others are available in the Prostate Cancer audio CD which is available on the web site www.CancerInPlainEnglish.com